Appropriate pharmacology should be initiated before, during and following percutaneous coronary intervention in patients with left ventricular dysfunction or heart failure

    loading  Checking for direct PDF access through Ovid


In patients undergoing percutaneous coronary intervention, adjunctive medication is determined by the degree of ischaemia. Optimal therapeutic interventions, especially in high-risk patients with left ventricular dysfunction and ischaemia, may improve survival and reduce morbidity associated with worsening heart failure. Several therapeutic options are available for use, which may be given prior to, during and after the procedure

    loading  Loading Related Articles